DENVER, Nov. 4, 2021 /PRNewswire/ -- DaVita Clinical
Research (DCR) will present eight research abstracts from company
representatives and medical professionals during the American
Society of Nephrology (ASN) Kidney Week occurring Nov. 4–7,
2021.
ASN Kidney Week 2021 will convene more than 13,000 kidney care
professionals from around the world in a virtual format to discuss
advancements in the field of nephrology.
"For decades, clinicians and researchers have come together
during Kidney Week to share new knowledge and build collaborations
that translate discoveries into clinical care," said Dr.
Steven Brunelli, vice president for
DCR. "We're eager to share our research contributing to the lives
and care of people living with kidney disease."
DaVita researchers will report on findings from multiple
retrospective and prospective studies, with a particular focus on
COVID-19 prevention and predictive tools for improving clinical
outcomes.
This year's poster and presentation titles, along with selected
study highlights, include:
- Development and Validation of an Algorithm to Predict Risk of
90-Day Hospitalization for Patients with Chronic Kidney
Disease
- Real-World Effectiveness and Immunogenicity of mRNA-1273 in
Dialysis Patients (Moderna)
- Real-World Effectiveness and Immunogenicity of BNT162b2 in
Dialysis Patients (Pfizer)
- Associations between Loop Diuretic Use and Outcomes among
Patients Treated with Peritoneal Dialysis
- A Novel Approach to Identify Nonclinical Factors that Impact
Outcomes in Dialysis Patients
- Safety of Bamlanivimab Treatment for COVID-19 Administered in
Dialysis Centers to Hemodialysis Patients
- Comparative Effectiveness of BNT162b2 and Ad26.COV2.S in the
Prevention of SARS-CoV-2 Infection among Dialysis Patients
- Perception of COVID-19 Risk among In-center Hemodialysis
Patients
Kidney Week attendees can view ePosters and pre-recorded
presentations from DCR and DaVita Kidney
Care clinical leaders at
https://www.asn-online.org/kidneyweek/ beginning Nov. 4. All meeting content will be posted online
until Jan. 7, 2022.
DaVita representatives will be available to discuss
collaboration opportunities in the Kidney Week digital exhibit
hall. Updates will be shared throughout the meeting on Twitter at
@DaVitaDoc and @DaVitaResearch. Attendees, as well as those who
cannot participate in the virtual sessions, are encouraged to join
or view the conversation by using #KidneyWk.
To learn more about DCR,
visit www.DaVitaClinicalResearch.com.
About DaVita Clinical Research
DaVita Clinical Research (DCR), a wholly owned subsidiary of DaVita
Inc., is the research arm of DaVita. DCR innovates through
retrospective research aimed at improving clinical outcomes. DCR
assists pharmaceutical and medical device companies in the design,
recruitment and completion of clinical trials using its renal
research site network. To learn more about DCR,
visit DaVitaClinicalResearch.com.
About DaVita Kidney Care
DaVita (NYSE: DVA) is a
health care provider focused on transforming care delivery to
improve quality of life for patients globally. The company is one
of the largest providers of kidney care services in the U.S. and
has been a leader in clinical quality and innovation for more than
20 years. DaVita cares for patients at every stage and setting
along their kidney health journey—from slowing the progression of
kidney disease to helping to support transplantation, from acute
hospital care to dialysis at home. As of September 30, 2021,
DaVita served 203,000 patients at 2,822 outpatient dialysis centers
in the United States. The
company also operated 333 outpatient dialysis centers in ten
countries worldwide. DaVita has reduced hospitalizations, improved
mortality, and worked collaboratively to propel the kidney care
industry to adopt an equitable and high-quality standard of care
for all patients, everywhere. To learn more,
visit DaVita.com/About.
Contact Information
Media:
Halie Peddle
(303) 550-6349
Halie.Peddle@DaVita.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/davita-clinical-research-to-present-new-findings-at-american-society-of-nephrology-kidney-week-2021-301416233.html
SOURCE DaVita Clinical Research